Source: BMC Pharmacology and Toxicology. Conference titles: Latin American Congress of Clinical and Laboratorial Toxicology - ToxiLatin. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, RECEPTORES DE DROGA, QUIMIOTERAPIA, ESTRÓGENOS
ABNT
XIMENEZ, João Paulo Bianchi et al. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s40360-019-0358-y. Acesso em: 21 out. 2024. , 2019APA
Ximenez, J. P. B., Andrade, J. M. de, Marques, M. P., Coelho, E. B., Suarez-Kurtz, G., & Lanchote, V. L. (2019). Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s40360-019-0358-yNLM
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2024 out. 21 ] Available from: https://doi.org/10.1186/s40360-019-0358-yVancouver
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2024 out. 21 ] Available from: https://doi.org/10.1186/s40360-019-0358-y